| Literature DB >> 20177577 |
Abstract
OBJECTIVE: To estimate the hepatoprotective effects of the methanolic seed extract of Eugenia jambolana Lam. (Myrtaceae), in Wistar albino rats treated with carbon tetrachloride (CCl(4)).Entities:
Keywords: Carbon tetrachloride; Eugenia jambolana Lam.; marker enzymes; methanolic extract
Year: 2009 PMID: 20177577 PMCID: PMC2825009 DOI: 10.4103/0253-7613.48888
Source DB: PubMed Journal: Indian J Pharmacol ISSN: 0253-7613 Impact factor: 1.200
The effect of methanolic seed extract of Eugenia jambolana Lam. on CCl4 induced hepatotoxicity in rats
| Group I | 37.78 ± 7.26 | 46.69 ± 10.74 | 12.45 ± 2.99 | 6.51 ± 0.52 | ||||
| Control with LP | ||||||||
| Group II | 93.16 7.92 | 99.68 ± 11.10 | 58.84 ± 14.75 | 14.01 ± 2.48 | ||||
| LP + CCl4 | ||||||||
| Group III | 52.14 ± 3.14 | 55.95 ± 5.57 | 27.79 ± 3.99 | 9.33 ± 0.98 | ||||
| LP + CCl4 + Liv.52® (1 ml/kg) | ||||||||
| Group IV | 75.11 ± 3.57 | 78.66 ± 4.87 | 54.71 ± 3.49 | 11.92 ± 0.49 | ||||
| LP + CCl4 + MT (100 mg/kg) | ||||||||
| Group V | 51.50 ± 2.08 | 73.94 ± 3.82 | 43.61 ± 5.54 | 10.71 ± 0.80 | ||||
| LP + CCl4 + MT (200 mg/kg) | ||||||||
| Group VI | 53.28 ± 6.97 | 68.50 ± 4.11 | 40.46 ± 3.05 | 10.72 ± 1.03 | ||||
| LP + CCl + MT (400 mg/kg) | ||||||||
| One Way F | 64.71 | 41 | 34.41 | 24.41 | ||||
| df | 5, 30 | 5, 30 | 5, 30 | 5, 30 | ||||
| | <0.001 | <0.001 | <0.001 | <0.001 | ||||
Values are represented as mean ± SEM (n = 6) in each group.
P ≤ 0.001 as compared to control rats.
P ≤ 0.05
P ≤ 0.01
P ≤ 0.001 as compared to CCl4 treated rats. LP- Liquid parafin
The effect of methanolic seed extract of Eugenia jambolana Lam. on bilirubin in CCl4 induced hepatotoxicity
| Group I | 0.74 ± 0.04 | 0.27 ± 0.03 | ||
| Control with LP | ||||
| Group II | 0.83 ± 0.02 | 0.41 ± 0.33 | ||
| LP + CCl4 | ||||
| Group III | 0.75 0.01 | 0.31 ± 0.02 | ||
| LP + CCl4 + Liv.52® (1 ml/kg) | ||||
| Group IV | 0.81 ± 0.03 | 0.31 ± 0.03 | ||
| LP + CCl4 + MT (100 mg/kg) | ||||
| Group V | 0.79 ± 0.01 | 0.34 ± 0.03 | ||
| LP + CCl4 + MT (200 mg/kg) | ||||
| Group VI | 0.75 ± 0.02 | 0.32 ± 0.03 | ||
| LP + CCl4 + MT (400 mg/kg) | ||||
| One Way F | 12.822 | 15.06 | ||
| 5, 30 | 5, 30 | |||
| | < 0.001 | < 0.001 | ||
Values are represented as mean ± SEM (n = 6) in each group.
P≤ 0.001 as compared to control rats.
*P≤ 0.05
P≤ 0.01
P≤0.001 as compared to CCl4 treated rats.
Figure 1Group I (Control): Section of liver with normal cell structure (→ arrow). 40×
Figure 2Group II (CCl4) Section of liver showing centriolobular necrosis (; arrow). 40×
Figure 3Group III (Liv.52®): Section of liver showing reduced necrotic area, normal cell structure (→ arrow) and necrotic cell(; arrow).40×
Figure 4Group IV (EJ 100): Section of liver showing reduced necrotic area. Note the vacuolar degeneration (; arrow). 40×
Figure 6Group VI (EJ 400): Section of liver showing significantly reduced necrotic area (; arrow) and vacuolar degeneration, normal cell structure (→; arrow) (40×)